oova.life

OOVA.life sells at-home diagnostic kits that measure multi-hormone fertility biomarkers; the flagship is a urine-based test strip system that pairs with a smartphone app to quantify progesterone and estrogen metabolites. Kits are priced at a premium level—about $159 for a 20-strip refill bundle—and are sold exclusively through the brand’s own e-commerce site, with subscription discounts and HSA/FSA eligibility. The company’s core edge is clinical-grade accuracy without a blood draw: the patented strip chemistry and AI-read camera module deliver lab-level hormone values in 10 minutes, then the app translates data into daily fertility scores and personalized cycle insights. OOVA is physician-founded, peer-reviewed, and used in major fertility clinics as an adjunct to cycle monitoring, positioning it as a medical device rather than a wellness novelty. Primary buyers are 25-40-year-old women with irregular cycles, PCOS, or recurrent pregnancy loss who want objective data to time intercourse or guide treatment discussions with reproductive endocrinologists. The brand appeals to science-minded consumers who value privacy, hate repeated clinic visits, and prefer evidence over basal-body-temperature guesswork. OOVA competes in the crowded fem-tech fertility space against both cheap ovulation-prediction strips and subscription hormone-mail services; it differentiates by offering real-time quantitative results for two key hormones on a single disposable strip, eliminating the wait and biohazard shipping required by saliva or blood-spot kits.